Genetics startup 23andMe raises $50 million Series D funding round

23andMe, the personal genetics company, has raised a $50 million Series D funding round to expand its users to one million individuals, drop the price of its Personal Genome Service to $99, and expand its infrastructure involved in its research capabilities.